Happy 2017! hang on...more layoffs coming

Quote




It's simple: pay close attention to national q1 numbers for diabetes portfolio. If on track, less layoffs mid year. If numbers behind, get ready for another layoff, this time since supposedly there's no DSS anymore (all rolled into primary care ). Just a way to place everyone into same title. So, if said territory has four diabetes reps and two respiratory, mid year you'll all be in same pot. Then the lucky ones will be chosen just prior to July 4 holiday. There's no possibility of not having at least another 700-1000 let go this year,bottom line. Anyone agree/disagree? You're not gonna hurt my feelings.
 




anonymous said:
It's simple: pay close attention to national q1 numbers for diabetes portfolio. If on track, less layoffs mid year. If numbers behind, get ready for another layoff, this time since supposedly there's no DSS anymore (all rolled into primary care ). Just a way to place everyone into same title. So, if said territory has four diabetes reps and two respiratory, mid year you'll all be in same pot. Then the lucky ones will be chosen just prior to July 4 holiday. There's no possibility of not having at least another 700-1000 let go this year,bottom line. Anyone agree/disagree? You're not gonna hurt my feelings.
Click to expand...

This seems true. Also remember, they will have Q1 numbers long before we get them, so they will already have an indication of how many will be let go. Restructure packages will already be drawn up with PSS names on them ready to be mailed out immediately after your mandatory teleconference.
 




anonymous said:
This seems true. Also remember, they will have Q1 numbers long before we get them, so they will already have an indication of how many will be let go. Restructure packages will already be drawn up with PSS names on them ready to be mailed out immediately after your mandatory teleconference.
Click to expand...

HQ source told us these layoffs would be rolled out in phases with the size and timing based on sales results.
It isn't a matter of if there will be layoffs, only the size, timing, and who. If Trump moves on forcing Pharma to negotiate pricing on Medicare Part D, then that will be a huge game changer.
 




anonymous said:
This seems true. Also remember, they will have Q1 numbers long before we get them, so they will already have an indication of how many will be let go. Restructure packages will already be drawn up with PSS names on them ready to be mailed out immediately after your mandatory teleconference.
Click to expand...

Just like Dec. heard that they had it all drawn up in July.
 




anonymous said:
It's simple: pay close attention to national q1 numbers for diabetes portfolio. If on track, less layoffs mid year. If numbers behind, get ready for another layoff, this time since supposedly there's no DSS anymore (all rolled into primary care ). Just a way to place everyone into same title. So, if said territory has four diabetes reps and two respiratory, mid year you'll all be in same pot. Then the lucky ones will be chosen just prior to July 4 holiday. There's no possibility of not having at least another 700-1000 let go this year,bottom line. Anyone agree/disagree? You're not gonna hurt my feelings.
Click to expand...

seems about right but at the risk of hurting your feelings some constructive criticism--watch your double negatives! 'no possibility of not having at least...'

it's better to say something with more punch: 'there's a 95-98% chance that at least 700-1,000 heads will get chopped before year-end'

Random I know but in-between inputing a couple of fake calls, I just watched a movie called 'True Story' starring James Franco and Jonah Hill about a disgraced New York Times writer who wrote a book about a guy (JF) who murdered his family. The NYT writer (played by JH) gave some good advice to beware of double negatives....
 








anonymous said:
Can you share where the cuts will come from? ESS, CV?
Click to expand...

Talk in HQ is we are moving more towards a consolidated sales force, fewer sales reps carrying more products. The trend of contract sales forces promoting mature brands continues and reduction in full time sales reps also will continue. Phase two announced before April.
 




anonymous said:
Talk in HQ is we are moving more towards a consolidated sales force, fewer sales reps carrying more products. The trend of contract sales forces promoting mature brands continues and reduction in full time sales reps also will continue. Phase two announced before April.
Click to expand...

Sounds about right. One rep with a cardio, resp. and diabetes drug. question is which dog will end up in tirtiary position? Hard to decide....
 




















anonymous said:
our CBD and EBD told us no layoff plans and I believe them.
Click to expand...

HQ source here. I hope you are joking because this is laughable and perhaps the simplest form of sarcasm.
These people are being told the same thing you are told. The only difference between them and us is they make more money for doing even less work. But they don't make any major decisions and are never told or consulted about whether we will have layoffs or not. Once the decision is made they will be sent a slide deck and told exactly what to say and when to say it so that we all hear it at the same time. Until then, stay tuned.
 




anonymous said:
CV force gone by summer. Restructure to include multiple meds in one bag
Click to expand...

Anyone making 6 figures and in a specialty other then oncology is gone. That will free up some cash to continue to overpay for the "talented" external oncology and biologic reps. They will be the only specialty care sales force going forward. Everyone else will be rolled into Primary Care, with continued cuts in this area whenever needed.Remember the chart they showed at BEM's in early 2016, showing more specialty care reps and less primary care? Well this is your roadmap.
 




anonymous said:
Anyone making 6 figures and in a specialty other then oncology is gone. That will free up some cash to continue to overpay for the "talented" external oncology and biologic reps. They will be the only specialty care sales force going forward. Everyone else will be rolled into Primary Care, with continued cuts in this area whenever needed.Remember the chart they showed at BEM's in early 2016, showing more specialty care reps and less primary care? Well this is your roadmap.
Click to expand...

100% accurate.
 




anonymous said:
HQ source here. I hope you are joking because this is laughable and perhaps the simplest form of sarcasm.
These people are being told the same thing you are told. The only difference between them and us is they make more money for doing even less work. But they don't make any major decisions and are never told or consulted about whether we will have layoffs or not. Once the decision is made they will be sent a slide deck and told exactly what to say and when to say it so that we all hear it at the same time. Until then, stay tuned.
Click to expand...

This made me laugh because I have heard senior leaders openly mocking a couple of the EBDs and CBDs.
One of them in particular is a target of jokes. Try to guess which one.
 












anonymous said:
BS to the post about $100k folks let go. That would mean all CL 4/5's, ESS's and some respect specialists. But wait it does make some sense. I call BS
Click to expand...

I think you missed the point of above poster. CL 4/5 are making well into the six figure range. Some of them were in specialty care and now moving over into primary care. Others have been in primary care for so long that they eventually had to move to CL 4/5 to move the MRP for better base pay and potential future raises. However, primary care is only going to pay so much. With that said, as eveyone gets lumped into primary care, anyone with CL 4/5 making six figures, can kiss their future raises goodbye. That is the unfortunate truth. I wont stay around for that. Im sure AZ is probably looking for other like me to do the same.
 




Top Bottom
Back
Quote